Login / Signup

Protocol of a monocentric, double-blind, randomized, superiority, controlled trial evaluating the effect of in-prison OROS-methylphenidate vs. placebo treatment in detained people with attention-deficit hyperactivity disorder (BATIR).

Stéphanie BaggioJoël BillieuxAnja DirkzwagerKatia IglesiasKarine MoschettiNader PerroudMarie SchneiderNathalie VernazHans WolffPatrick Heller
Published in: Trials (2024)
ClinicalTrials.gov NCT05842330 . Registered on June 5, 2023. Kofam.ch SNCTP000005388. Registered on July 17, 2023.
Keyphrases
  • double blind
  • placebo controlled
  • clinical trial
  • phase iii
  • phase ii
  • open label
  • study protocol
  • attention deficit hyperactivity disorder
  • randomized controlled trial
  • autism spectrum disorder
  • room temperature